RE: Strong update form NCYT3 Dec 2021 10:12
Therefore, based on the currently available analysis of the sequences, as of 29th November 2021,
we are confident that the performance of all Novacyt products, intended for primary SARS-CoV-2
testing, are unaffected by the emergence of the Omicron variant.
Please refer to Appendix 1 for the full list of our assays that are unaffected by the Omicron variant.
Kindly contact your dedicated Novacyt sales personnel or us at enquiries@primerdesign.co.uk
should you need more information.